Ainos, Inc. Files 8-K Report

Ticker: AIMDW · Form: 8-K · Filed: Aug 13, 2025 · CIK: 1014763

Sentiment: neutral

Topics: corporate-filing, 8-k, pharmaceuticals

TL;DR

Ainos, Inc. filed an 8-K on 8/13/25, confirming their fiscal year end and business sector.

AI Summary

On August 13, 2025, Ainos, Inc. filed an 8-K report. The filing indicates the company's fiscal year ends on December 31st. Ainos, Inc. is incorporated in Texas and its principal business is in Pharmaceutical Preparations.

Why It Matters

This 8-K filing provides an update on Ainos, Inc.'s corporate status and financial reporting schedule, which is important for investors to track.

Risk Assessment

Risk Level: low — This filing is a routine corporate disclosure and does not contain significant new financial or operational information that would immediately impact risk.

Key Numbers

Key Players & Entities

FAQ

What is the primary business of Ainos, Inc.?

Ainos, Inc.'s primary business is in Pharmaceutical Preparations, as indicated by its Standard Industrial Classification code 2834.

When is Ainos, Inc.'s fiscal year end?

Ainos, Inc.'s fiscal year ends on December 31st.

In which state is Ainos, Inc. incorporated?

Ainos, Inc. is incorporated in Texas.

What is the Commission File Number for Ainos, Inc.?

The Commission File Number for Ainos, Inc. is 001-41461.

What is the IRS Employer Identification Number for Ainos, Inc.?

The IRS Employer Identification Number for Ainos, Inc. is 751974352.

Filing Stats: 524 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2025-08-13 16:30:27

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Ainos, Inc. Date: August 13, 2025 By: /s/ Chun-Hsien Tsai Name: Chun-Hsien Tsai Title: Chief Executive Officer 3

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing